Reza Zadno - Procept Biorobotics CEO President
| PRCT Stock | USD 52.05 0.22 0.42% |
CEO
Reza Zadno is CEO President of Procept Biorobotics Corp
| Age | 69 |
| Address | 150 Baytech Drive, San Jose, CA, United States, 95134 |
| Phone | 650 232 7200 |
| Web | https://www.procept-biorobotics.com |
Latest Insider Transactions
Reza Zadno Latest Insider Activity
Tracking and analyzing the buying and selling activities of Reza Zadno against Procept Biorobotics stock is an integral part of due diligence when investing in Procept Biorobotics. Reza Zadno insider activity provides valuable insight into whether Procept Biorobotics is net buyers or sellers over its current business cycle. Note, Procept Biorobotics insiders must abide by specific rules, including filing SEC forms every time they buy or sell Procept Biorobotics'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Reza Zadno over six months ago Exercise or conversion by Reza Zadno of 5148 shares of Procept Biorobotics subject to Rule 16b-3 | ||
Reza Zadno over six months ago Exercise or conversion by Reza Zadno of 19995 shares of Procept Biorobotics subject to Rule 16b-3 | ||
Reza Zadno over a year ago Exercise or conversion by Reza Zadno of 20022 shares of Procept Biorobotics subject to Rule 16b-3 |
Procept Biorobotics Management Efficiency
The company has return on total asset (ROA) of (0.1911) % which means that it has lost $0.1911 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4433) %, meaning that it created substantial loss on money invested by shareholders. Procept Biorobotics' management efficiency ratios could be used to measure how well Procept Biorobotics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.28 in 2024. Return On Capital Employed is likely to drop to -0.32 in 2024. At this time, Procept Biorobotics' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 26.1 M in 2024.Similar Executives
| Found 2 records | CEO Age | ||
| Samuel Hazen | HCA Holdings | 64 | |
| Debra Osteen | Acadia Healthcare | 62 | |
Management Performance
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.19 |
Procept Biorobotics Corp Leadership Team
Elected by the shareholders, the Procept Biorobotics' board of directors comprises two types of representatives: Procept Biorobotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procept. The board's role is to monitor Procept Biorobotics' management team and ensure that shareholders' interests are well served. Procept Biorobotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procept Biorobotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthew CFA, Vice Relations | ||
| Hisham Shiblaq, Executive Officer | ||
| Stacey Porter, Chief Officer | ||
| Minni Vittal, VP Officer | ||
| Reza Zadno, CEO President | ||
| Kevin Waters, Executive CFO | ||
| Alaleh Nouri, Chief EVP | ||
| Mohan Sancheti, Senior Operations | ||
| Thomas Yorkey, VP RD | ||
| Bijesh Chandran, Senior Assurance | ||
| Barry Templin, Executive Development |
Procept Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procept Biorobotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.78) % | ||||
| Operating Margin | (0.68) % | ||||
| Current Valuation | 2.48 B | ||||
| Shares Outstanding | 51.4 M | ||||
| Shares Owned By Insiders | 3.56 % | ||||
| Shares Owned By Institutions | 90.87 % | ||||
| Number Of Shares Shorted | 5.36 M | ||||
| Price To Book | 9.22 X |
Procept Biorobotics Investors Sentiment
The influence of Procept Biorobotics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Procept. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Procept Biorobotics' public news can be used to forecast risks associated with an investment in Procept. The trend in average sentiment can be used to explain how an investor holding Procept can time the market purely based on public headlines and social activities around Procept Biorobotics Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Procept Biorobotics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Procept Biorobotics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Procept Biorobotics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Procept Biorobotics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Procept Biorobotics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Procept Biorobotics' short interest history, or implied volatility extrapolated from Procept Biorobotics options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procept Biorobotics Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procept Biorobotics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Procept Biorobotics Corp information on this page should be used as a complementary analysis to other Procept Biorobotics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Procept Stock analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Procept Biorobotics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procept Biorobotics. If investors know Procept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procept Biorobotics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.24) | Revenue Per Share 2.882 | Quarterly Revenue Growth 0.833 | Return On Assets (0.19) | Return On Equity (0.44) |
The market value of Procept Biorobotics Corp is measured differently than its book value, which is the value of Procept that is recorded on the company's balance sheet. Investors also form their own opinion of Procept Biorobotics' value that differs from its market value or its book value, called intrinsic value, which is Procept Biorobotics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procept Biorobotics' market value can be influenced by many factors that don't directly affect Procept Biorobotics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procept Biorobotics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Procept Biorobotics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procept Biorobotics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.